Denali Therapeutics Inc. Common Stock DNLI
$20.14
+2.44%
at last close
Financials (TTM)
- Revenue
- —
- Net Income
- $-508,017,000
- Net Margin
- —
- Return on Equity
- -54.86%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 3.37
- Price / Sales
- —
Over the trailing twelve months, Denali Therapeutics Inc. Common Stock generated revenue of — and net income of $-508,017,000.
Key Stats
- Last Close
- $20.14
- Market Cap
- $3.12 billion
- 52-Week Range
- $12.58 – $23.77
- Average Volume
- 1.82 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.